Literature DB >> 17040270

Treatment of chronic erythema nodosum with infliximab.

T H Clayton, B P Walker, G I Stables.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17040270     DOI： 10.1111/j.1365-2230.2006.02221.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  7 in total

1.  [Disseminated erythema nodosum].

Authors:  R Mota; D Bruch-Gerharz; R Kruse; U R Hengge
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

Review 2.  Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.

Authors:  Paul E Evans; Darrell S Pardi
Journal:  MedGenMed       Date:  2007-03-19

Review 3.  Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Jurij Hanzel; Christopher Ma; Niels Vande Casteele; Reena Khanna; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 4.  Skin Manifestations of Inflammatory Bowel Disease.

Authors:  Thomas Greuter; Alexander Navarini; Stephan R Vavricka
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 5.  Current clinical issue of skin lesions in patients with inflammatory bowel disease.

Authors:  Tomoya Iida; Tokimasa Hida; Minoru Matsuura; Hisashi Uhara; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2019-03-05

Review 6.  Extraintestinal Manifestations of Inflammatory Bowel Disease.

Authors:  Stephan R Vavricka; Alain Schoepfer; Michael Scharl; Peter L Lakatos; Alexander Navarini; Gerhard Rogler
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

Review 7.  Erythema Nodosum: A Practical Approach and Diagnostic Algorithm.

Authors:  Daniela Michelle Pérez-Garza; Sonia Chavez-Alvarez; Jorge Ocampo-Candiani; Minerva Gomez-Flores
Journal:  Am J Clin Dermatol       Date:  2021-03-08       Impact factor: 7.403
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.